Last updated 2 months ago

Safety and Efficacy of Venetoclax, Cytarabine and Metformin (VenCM) for Relapsed-Refractory and Induction-Ineligible Acute Myeloid Leukemia

100 patients around the world
Available in Brazil
Subjects will be included voluntarily after informed consent. Diagnosis of AML in accordance with the WHO classification and determination of inegibility to induction therapy or refractory or relapsed disease after initial treatment.
Hospital Municipal São José
4Research sites
100Patients around the world
This study is for people with
Leukemia
Acute myeloid leukemia
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Hospital Ophir Loyola
Av. Gov Magalhães Barata, 992 - São Brás, Belém - PA, 66060-281, Brazil
Hospital De Clínicas Da Universidade Federal Do Paraná
R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900
Polydoro Ernani de São Thiago University Hospital
R. Profa. Maria Flora Pausewang - Trindade, Florianópolis - SC, 88036-800
Hospital Amaral Carvalho
Recruiting
R. Doná Silvéria, 150 - Chácara Braz Miraglia, Jaú - SP, 17210-080, Brazil
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy